AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitamay M Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitamay M Tablet

Diabexe Duo tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like nephropathy and vision loss, potentially lowering heart attack and stroke risks. Diabexe Duo may be used independently or alongside other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood sugar readings, and concomitant medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Continued commitment to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Hypoglycemia, a potential side effect when combined with insulin or sulfonylureas, necessitates understanding its recognition and management. This medication isn't universally suitable. Prior to commencing treatment, disclose any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption to your physician. Pregnant or lactating women should seek medical counsel before use. Interactions with other medications are possible; therefore, inform your doctor about all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Sitamay M Tablet

Managing type 2 diabetes

Major Benefits of Sitamay M Tablet:

Administer this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Sitamay M Tablet with a meal.

Common Side effects of Sitamay M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamay M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitamay M Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Sitamay M Tablet works:

Sitamay M Tablet combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action facilitates superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sitamay M Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitamay M Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitamay M Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitamay M Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitamay M Tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitamay M Tablet is potentially hazardous for individuals with hepatic impairment and is best avoided. Medical advice is recommended.

What if you forget to take Sitamay M Tablet :

Should you forget a dose of Sitamay M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitamay M Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Sitamay M Tablet

The tablet Sitamay M combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and increases insulin sensitivity. Sitagliptin's mechanism involves DPP-4 enzyme inhibition, boosting insulin secretion from the pancreas. Sitamay M is unsuitable for individuals under 18.
Prolonged Sitamay M Tablet consumption can indeed lead to vitamin B12 deficiency. This is due to the medication's interference with the body's absorption of vitamin B12 in the gastrointestinal tract. Untreated deficiency may manifest as anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Sitamay M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamay M Tablet constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamay M Tablet and alcohol is unsafe due to the heightened risk of lactic acidosis.
Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition stemming from excessive blood lactic acid, is a potential complication of Sitamay M Tablet use. This adverse reaction, also termed MALA (Metformin-associated lactic acidosis), though infrequent, necessitates caution. Therefore, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Characteristic symptoms encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Sitamay M Tablet and seek immediate medical attention.
Sitamay M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitamay M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitamay M Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitamay M Tablet is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Sitamay M Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but warrants caution. Its occurrence is heightened in individuals with pre-existing kidney impairment, the elderly, and those who consume significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should any of these symptoms arise, discontinue Sitamay M Tablet and seek immediate medical attention.
Prolonged Sitamay M Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include supplemental vitamin B12 intake at least annually.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitagliptin and Metformin, combined as Sitamay M Tablet, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and exercise regimen. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin blocks DPP4, thus boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitamay M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Individuals with hypersensitivity to Sitamay M Tablet constituents or inactive ingredients should not use this medication. Its use is contraindicated in patients exhibiting severe renal dysfunction, hepatic insufficiency, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamay M Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Sitamay M Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but warrants caution. Its occurrence is heightened in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption; hence, the medication is contraindicated in these populations. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitamay M Tablet and seek immediate medical attention.
Prolonged Sitamay M Tablet consumption can indeed lead to vitamin B12 deficiency. This medication impairs the body's absorption of vitamin B12 within the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, general weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at minimum annually, is recommended by some experts.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitamay M Tablet
118
MRP 137
13% off